Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Over the past decade, immune checkpoint inhibitors have transformed cancer care for a variety of tumor types. This form of immunotherapy can lead to long-lasting...
At the time of this writing, more than 3.3 million individuals have been diagnosed with COVID-19, and more than 222,000 have died from the...
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
The excitement surrounding this week’s AACR Virtual Meeting I – which drew more than 61,000 people on the first day – can’t stop us from delivering the latest edition of Editors’...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...
The cutting-edge scientific program for the AACR Virtual Annual Meeting I began Monday, April 27, with an Opening Clinical Plenary featuring...
While the incidence of melanoma has been rising, the mortality rate has experienced a steep decline over the past few years. This is largely attributable...
In an extraordinary turn of events, the American Association for Cancer Research (AACR) Annual Meeting 2020 kicked off Monday...
As the COVID-19 pandemic swept the globe this spring, the American Association for Cancer Research (AACR) launched a major...
Testicular cancer forms when cancerous cells develop in one or both testicles. Almost all cases of the disease begin...